Dynamic International Prognostic Scoring System scores, pre-transplant therapy and chronic graft-versus-host disease determine outcome after allogeneic hematopoietic stem cell transplantation for myelofibrosis | Haematologica
PDF) Application of Stem Cell Therapy in Myelofibrosis
PDF] Comprehensive clinical-molecular transplant scoring system for myelofibrosis undergoing stem cell transplantation. | Semantic Scholar
PDF] Comprehensive clinical-molecular transplant scoring system for myelofibrosis undergoing stem cell transplantation. | Semantic Scholar
Secondary Myelofibrosis in the Naturel History of JAK2, MPL and C
PDF) Primary myelofibrosis: risk stratification by IPSS identifies patients with poor clinical outcome | Marcia Delamain - Academia.edu
Myelofibrosis – What's in a Name? | Semantic Scholar
PDF] Comprehensive clinical-molecular transplant scoring system for myelofibrosis undergoing stem cell transplantation. | Semantic Scholar
Prognostic markers | PPT
PDF] Comprehensive clinical-molecular transplant scoring system for myelofibrosis undergoing stem cell transplantation. | Semantic Scholar
PDF) Primary myelofibrosis: Risk stratification by IPSS identifies patients with poor clinical outcome
Risk stratification and prognosis prediction in 726 patients with... | Download Scientific Diagram
Discrepancies of applying primary myelofibrosis prognostic scores for patients with post polycythemia vera/essential thrombocytosis myelofibrosis | Haematologica
PDF) The outcome of allo-HSCT for 92 patients with myelofibrosis in the Nordic countries
Biological drivers of clinical phenotype in myelofibrosis | Leukemia
Transplant Decisions in Patients with Myelofibrosis: Should Mutations Be the Judge? - Biology of Blood and Marrow Transplantation
PDF) Primary myelofibrosis: risk stratification by IPSS identifies patients with poor clinical outcome | Carmen Lima - Academia.edu
Emerging treatment options for myelofibrosis: focus on pacritinib | OTT
New prognostic scoring system for primary myelofibrosis based on a study of the International Working Group for Myelofibrosis Research and Treatment - ScienceDirect
Antilymphocyte globulin for matched sibling donor transplantation in patients with myelofibrosis | Haematologica